- Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
- Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
- Joined-up preclinical and clinical trials to advance psilocybin drug development
- Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
- Announcing new premises in Poland with a focus on neuropsychiatric disorders...
- New state-of-the-art premises at Discovery Park, Kent
Conferences
11 to 13 November 2019 Hamburg, Germany
Transpharmation and co-marketing partners InterVivo Solutions will be attending the BioEurope, Europe's largest life science partnering conference. This meeting represents an ideal opportunity for us to engage with our clients and vice versa. So, if you are attending please do visit us and find out more about how Transpharmation's knowledge and services can benefit your research.
19 to 23 October 2019 Chicago, USA
Transpharmation will again be attending the annual Society for Neuroscience meeting, which this year will be held in Chicago, USA. We'll have our largest ever team in attendance and will be proudly launching our new branding at booth 1810. We'll also be presenting a number of posters covering diverse research areas such as The NMDA Receptor Antagonist Ketamine Exerts Biphasic Effects on Mismatch Negativity in the Rat by Sandor Kantor.
Jack Prenderville, from our Irish facility, will also be co-organizing an Irish Neuroscience Gathering during SfN. This is an opportunity for Irish neuroscientists to meet and discuss the latest news and research developments over a drink in an Irish pub (of course!). If you would like more details please contact us.
- You are here:
- Home
- Conferences
- 2019 Conferences
Our clients are our partners.
We work hard around the globe to create breakthrough results for them.
+48 515 244 120